Mutations That Confer Resistance to Template-Analog Inhibitors of Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Lead to Severe Defects in HIV Replication

Similar Items

• Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by Template Analog Reverse Transcriptase Inhibitors Derived by SELEX (Systematic Evolution of Ligands by Exponential Enrichment)
  od: Joshi, Pheroze, i dr.
  Izdano: (2002)
• HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT1t49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors
  od: Fisher, Timothy S, i dr.
  Izdano: (2005)
• Hypersusceptibility to Substrate Analogs Conferred by Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  od: Smith, Robert A., i dr.
  Izdano: (2006)
• Interaction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins
  od: Hehl, Eric A., i dr.
  Izdano: (2004)
• Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication
  od: Paolucci, Stefania, i dr.
  Izdano: (2004)